Cost-effectiveness of longer-term treatment with eszopiclone 3mg in adults with primary insomnia

被引：1
|
作者：
Botteman, M
Ozminkowski, R
Wang, S
Pashos, CL
Foley, DJ
Schaefer, K
机构：
[1] Abt Associates Inc, Bethesda, MD USA
[2] Medstat Grp, Ann Arbor, MI USA
[3] Medstat Grp, Cambridge, MA USA
[4] Abt Associates Inc, Lexington, MA USA
[5] US Subst Abuse & Mental Hlth Serv Adm, Rockville, MD USA
[6] Sepracor Inc, Marlborough, MA USA
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62843-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：323 / 323
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of eszopiclone for the treatment of adults with primary insomnia
    Snedecor, S. J.
    Botteman, M. F.
    Schaefer, K.
    Barry, N.
    Pickard, A.
    [J]. SLEEP, 2008, 31 : A246 - A246
  • [2] Cost-Effectiveness of Eszopiclone for the Treatment of Adults with Primary Chronic Insomnia
    Snedecor, Sonya J.
    Botteman, Marc F.
    Bojke, Chris
    Schaefer, Kendyl
    Barry, Nadine
    Pickard, A. Simon
    [J]. SLEEP, 2009, 32 (06) : 817 - 824
  • [3] Cost-effectiveness of eszopiclone for the treatment of adults with primary insomnia in the US
    Bell, C.
    Snedecor, S. J.
    Botteman, M. F.
    Schaefer, K.
    Pickard, A. S.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 305 - 305
  • [4] An analytical model to predict the cost-effectiveness of long-term eszopiclone for the treatment of primary insomnia
    Snedecor, S. L.
    Botteman, M. F.
    Schaefer, K.
    Barry, N.
    Rubens, R.
    Pickard, A. S.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A381 - A382
  • [5] Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults - A decision analytical model
    Botteman, Marc F.
    Ozminkowski, Ron J.
    Wang, Shaohung
    Pashos, Chris L.
    Schaefer, Kendyl
    Foley, Daniel J.
    [J]. CNS DRUGS, 2007, 21 (04) : 319 - 334
  • [6] Cost Effectiveness of Long-Term Treatment with Eszopiclone for Primary Insomnia in AdultsA Decision Analytical Model
    Marc F. Botteman
    Ron J. Ozminkowski
    Shaohung Wang
    Chris L. Pashos
    Kendyl Schaefer
    Daniel J. Foley
    [J]. CNS Drugs, 2007, 21 : 319 - 334
  • [7] The effects eszopiclone 3mg on next day driving ability, cognitive and psychomotor function in patients with primary insomnia
    Wessell, T.
    Caron, J.
    Trick, L.
    Rubens, R.
    Roach, J.
    Boyle, J.
    [J]. EUROPEAN PSYCHIATRY, 2007, 22 : S248 - S248
  • [8] TREATMENT WITH ESZOPICLONE IN ADULTS WITH PRIMARY INSOMNIA: PREDICTORS OF RESPONSE
    Marshall, R. D.
    Grinnell, T.
    Zummo, J.
    Schweizer, E.
    [J]. SLEEP, 2011, 34 : A177 - A177
  • [9] Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: A decision analytical model. (vol 21, pg 319, 2007)
    Botteman, M. F.
    Ozminkowski, R. J.
    Wang, S.
    Pashos, C. L.
    Schaefer, K.
    Foley, D. J.
    [J]. CNS DRUGS, 2007, 21 (05) : 405 - 405
  • [10] Cluster Randomized Controlled Trial Clinical and Cost-Effectiveness of a System of Longer-Term Stroke Care
    Forster, Anne
    Young, John
    Chapman, Katie
    Nixon, Jane
    Patel, Anita
    Holloway, Ivana
    Mellish, Kirste
    Anwar, Shamaila
    Breen, Rachel
    Knapp, Martin
    Murray, Jenni
    Farrin, Amanda
    [J]. STROKE, 2015, 46 (08) : 2212 - 2219
12345